These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34528236)

  • 1. Transcriptomic changes during stage progression of mycosis fungoides.
    Xiao MZX; Hennessey D; Iyer A; O'Keefe S; Zhang F; Sivanand A; Gniadecki R
    Br J Dermatol; 2022 Mar; 186(3):520-531. PubMed ID: 34528236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
    de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.
    Rindler K; Jonak C; Alkon N; Thaler FM; Kurz H; Shaw LE; Stingl G; Weninger W; Halbritter F; Bauer WM; Farlik M; Brunner PM
    Mol Cancer; 2021 Sep; 20(1):124. PubMed ID: 34583709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
    Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
    Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
    Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
    Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).
    Willerslev-Olsen A; Litvinov IV; Fredholm SM; Petersen DL; Sibbesen NA; Gniadecki R; Zhang Q; Bonefeld CM; Wasik MA; Geisler C; Zhou Y; Woetmann A; Sasseville D; Krejsgaard T; Odum N
    Cell Cycle; 2014; 13(8):1306-12. PubMed ID: 24621498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA.
    Asadullah K; Döcke WD; Haeussler A; Sterry W; Volk HD
    J Invest Dermatol; 1996 Dec; 107(6):833-7. PubMed ID: 8941670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Neoantigen Landscape of Mycosis Fungoides.
    Sivanand A; Hennessey D; Iyer A; O'Keefe S; Surmanowicz P; Vaid G; Xiao Z; Gniadecki R
    Front Immunol; 2020; 11():561234. PubMed ID: 33329522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD31 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
    Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary skin lesions with histopathologic features of early mycosis fungoides.
    Cerroni L; Fink-Puches R; El-Shabrawi-Caelen L; Soyer HP; LeBoit PE; Kerl H
    Am J Dermatopathol; 1999 Dec; 21(6):518-24. PubMed ID: 10608243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-related increase in PIM2 expression in mycosis fungoides.
    Nielsen MH; Nielsen PR; Bzorek M; Eriksen JO; Wehkamp U; Lindahl LM; Woetmann A; Ødum N; Litman T; Gjerdrum LMR
    APMIS; 2024 Aug; 132(8):564-570. PubMed ID: 38757234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis.
    Lai J; Li J; Gniadecki R; Lai R
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.
    Alcántara-Hernández M; Torres-Zárate C; Pérez-Montesinos G; Jurado-Santacruz F; Domínguez-Gómez MA; Peniche-Castellanos A; Ferat-Osorio E; Neri N; Nambo MJ; Alvarado-Cabrero I; Moreno-Lafont M; Huerta-Yepez S; Bonifaz LC
    Int J Cancer; 2014 May; 134(9):2136-45. PubMed ID: 24127318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.